RxDoctor Payments Data

Ryan Selley, MD

Orthopaedic Surgery · Chicago, ILNPI 1437544988

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (40.4%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Smith+Nephew at 40.7% of the total. Reporting peaked in 2020 at $26,983 and has fallen 86.9% since, to $3,543 in 2025. Among orthopaedic surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$87,548in general payments, 2019–2025

Across 216 payments — averaging $405.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$36K
  • Arthrex$25K
  • Medacta USA, Inc.$15K
  • Stryker$7K
  • Medwest Associates$2K
  • Gotham Surgical Solutions & Devices, Inc.$468
  • plus $2K from 7 others

What the payments were for

  • Consulting fees$2,4003%
  • Grants$16,66719%
  • Travel & lodging$23,45927%
  • Food & beverage$9,68411%
  • Education$35,33940%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$87,548 in reported general payments places this provider in the 90th percentile of 844 orthopaedic surgery providers in Illinois.

See all orthopaedic surgery providers in Illinois →

Medicare billing

Part B allowed, 2024
$86,255
Medicare patients
229
Services billed
728

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin16$110
Meloxicam12$14

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Chicago

See the full list for Illinois →

Where these figures come from

Is this you, or does something look wrong? →